TB DIAGNOSTICS R&D: Not Just Technology Peter Mehlape, General Manager GBC Southern Africa Conference 11th October 2010, Johannesburg BD Experience with.

Slides:



Advertisements
Similar presentations
Draft logframe of Round 11 HSS proposal Proposal Development Task Team (PDTT) – Executive Team Friday, 7 October 2011.
Advertisements

Dr R Ramachandran 5 th Joint International Monitoring Mission to Review NTP Thailand 5th JMM Thailand.
The Way Ahead How can we make a difference for good as a result of this meeting? What problems are we trying to solve? Laboratory Capacity? Clinical/Diagnostics,
Implementation of Diagnostics in Resource-Limited Settings Amy Piatek Global Health Bureau, Office of Health, Infectious Diseases & Nutrition U.S. Agency.
Re-thinking Health: Making health a mission priority for Anglican Alliance and its regions. Emmanuel Olatunji, Africa Facilitator for Anglican Alliance.
Presentation to the 2014 International AIDS Conference
Medicines Transparency Alliance (MeTA) Presented to CSO workshops during 2013 in SOLWEZI AUGUST 27 NDOLA AUGUST 29 LUSAKA OCTOBER 22.
TUBERCOLOSIS Agis Terzidis, Paediatrician Spyridon Gialamas, Medical Doctor SEMINAR ON TROPICAL AND TRAVEL MEDICINE AT TTCIH IFAKARA 25 JUNE 2009.
Laboratory accreditation Impact on Patient Care & Health System
Generating evidence for change: Implementing the post-ICIUM research agenda Dennis Ross-Degnan, ScD Harvard Medical School and Harvard Pilgrim Health Care.
The South African Malaria Initiative A Case Study E Jane Morris Bridging the Gap in Global Health Innovation - from Needs to.
African Business Leaders on Health GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 2010 Technical Assistance.
Challenge 4: Linking TB & HIV/AIDS Programs Kayt Erdahl, Project HOPE Rodrick Nalikungwi, Project HOPE Malawi December 18, 2008.
The Value of Partnerships in Fighting HIV/AIDS in Romania: Bringing Children New Hope Jeffrey L. Sturchio Vice President, External Affairs Europe, Middle.
Criteria for Centres of Expertise for Rare Diseases in the EU following EUCERD Recommendations RARECARENet Project: Consensus meeting on.
Partnerships in Promoting Innovation and Managing Risk Scientific and Financial Innovation in AIDS Vaccines International AIDS Vaccine Initiative Labeeb.
Biosafety and Biosecurity Challenges in the Caribbean Region Valerie Wilson Caribbean Med Labs Foundation Anticipating Global Biosecurity Challenges Istanbul,
Operational Research in the 21 st Century. International Union Against Tuberculosis and Lung Disease (The Union) World’s oldest humanitarian organization.
1 © 2007 Avaya Inc. All rights reserved. Avaya – Proprietary & Confidential. Under NDA Avaya - Proprietary & Confidential. For Internal Use Only. Avaya.
The Importance of private-public parternship for a successful road transport profesionnal training model Jamil Mujahed Director General Land Transport.
Group Discussion Guyana, The Bahamas T & T, Jamaica Barbados, Haiti Suriname, Curacao.
WHO Expert Working Group on R&D Financing Stop TB New Tools Working Groups Marcos Espinal Executive Secretary.
Medicines Transparency Alliance01/10/2015 Availability of Medicines Anita Wagner Harvard Medical School & WHO Collaborating Center in Pharmaceutical Policy.
AMFm Overview and Case Management Observations RBM Case Management Working Group (CMWG)
Botswana Experience on Public- Private Partnerships Joconiah Chirenda, MD, MPH, MBA Global Business Coalition on.
TB PUBLIC-PRIVATE MIX DOTS Dr. Team Bakkhim Deputy Director CENAT Intercontinental Hotel 7 th November, 2012 NATIONAL FORUM ON PUBLIC-PRIVATE PARTNERSHIP.
FIND Ongoing Activities What’s in the pipeline for Rapid DST? WHO Stop TB Department Supranational Reference Laboratory Network Meeting Paris, October.
Missed opportunities to diagnose TB and HIV Co-infection in HIV workplace program Dr Fred Mugyenyi Asiimwe Medical Director, ALAFA.
The Global Fund-Private Sector Survey Feedback on preliminary findings GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg,
Johannesburg, 13 th August 2009 Outstanding Business Action to Stop TB: How Companies Contribute to the Global Fight 2009 TB Case Studies Shuma Panse Global.
Approach and Impact Support for Public Health ECOSOC Special Event on Philanthropy United Nations 23 February, 2009.
1 E-Health Source: Information Systems for Healthcare Management, 6th Edition Authors: Charles J. Austin and Stuart B. Boxerman Health Administration Press.
TB/HIV COLLABORATION IN GHANA Dr. Nii Nortey Hanson – Nortey National TB Control Programme Accra.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
Christo van Niekerk, M.D. Senior Director, Clinical Development Pretoria, South Africa Innovating TB Treatment: Opportunities for Private Sector Engagement.
TB Public Private Partnerships Opportunity or Risk? Cheri Vincent Senior Public Health Advisor USAID June 3, 2008.
Global Business Coalition Conference on TB/HIV Health Vulnerabilities of Mine Workers Natalie Ridgard Migration Health Project Officer International Organization.
PERSPECTIVES FROM THE FIELD DR LYDIA MUNGHERERA TASO (The Aids Support Organisation) UGANDA REVERSING THE TIDE OF TB.
Establishing a Global Vaccine Development Fund Peter Hale The Foundation for Vaccine Research Washington, DC Consultation on Financing of R&D Preparedness.
Report of the 2nd ad hoc Committee on the TB epidemic Jaap F. Broekmans STOP TB Partner’s Forum NEW DELHI June 2004.
Meeting of the Working Group on TB Drug Development Why you need to be engaged? Marcos Espinal Executive Secretary Stop TB Partnership 29 October 2004.
“28,424 cases of Ebola and still counting—what have we learned
Indiana Logistics Summit October 19, Supply Chain Strategy & Real Estate Overview: Becton Dickinson - BD Strategic Decision Making Network Rationalization.
TB infection control and prevention of XDR Group II.
Pharmacovigilance in HIV/AIDS Public Health Programmes: Luxury or Priority? November 2009, dar Es Salaam.
3rd WHO Prequalification Stakeholders Meeting :Diagnostics 3rd Stakeholders Meeting on Prequalification Geneva, 4th February 2008 Update on Prequalification.
Antibiotic resistance: National actions contribute to a global solution NEPAL Professor Paras K Pokharel Vice Chair GARP Nepal.
ANNIE BANDA Executive Director –COALITION OF WOMEN AND GIRLS LIVING WITH HIV & AIDS- COWLHA 15 th APRIL 2014 Johannesburg, South Africa OPPORTUNITIES AND.
ARV Treatment Scale Up: Progress in Ukraine Andriy Klepikov Executive Director, International HIV/AIDS Alliance in Ukraine ARV Treatment Scale Up: Progress.
Road Map to a Successful PT/EQA Scheme- The HuQAS Experience Michael Kamiru.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
© 2014 GS1 US ALL RIGHTS RESERVED Making a Difference 1.
CDC and support for Point of Care Testing Accreditation Muthoni Junghae CDC-Kenya LAUNCH OFF POINT OF CARE TESTING ACCREDITATION PROGRAM PANAFRIC HOTEL-18TH.
EDM Strategy for Working with Countries: the Uganda Example
LEAP: Contributing to Strengthening Clinical Trial Capacity, Treatment and Control of VL in Eastern Africa Asrat Hailu, LEAP Chair, Addis Ababa University.
Presented by: Vernice Davis Anthony President and CEO
USDA-Africa Partnerships to Mitigate Aflatoxins
WHO Medicines Work in Countries: The Kenya Example
East African Drug Seller Initiative Uganda Sensitization Meeting
National Programme for limiting spread of HIV/AIDS in Latvia 2008–2012
Innovative Medicines Initiative:
The Role of Bilateral Donors in supporting capacity-building in the area of ICT Open Consultations on Financing Mechanisms for Meeting the Challenges.
Engagement of Informal Health Care Providers Increases Referrals and Successful Outcome of TB patients in Tribal District of India Using Mobile Technology.
The Role of NICs in Influenza Surveillance
USDA-Africa Partnerships to Mitigate Aflatoxins
Ministry of Health, Kenya
Fabio Scano IUATLD Conference Paris, 2003
USDA-Africa Partnerships to Mitigate Aflatoxins
Costs of Operating Population-Based Cancer Registries: Results from Four Sub-Saharan African Countries Florence Tangka, PhD Senior Health Economist, Division.
A pathway to policy commitment for sustainability of a key population-led health services model in Thailand Dr. Preecha Prempree Deputy Director-General,
Presentation transcript:

TB DIAGNOSTICS R&D: Not Just Technology Peter Mehlape, General Manager GBC Southern Africa Conference 11th October 2010, Johannesburg BD Experience with Implementation & Support

About BD (Becton, Dickinson and Co.) Medical Technology Company  $7.5B  Offices in 52 countries  29,000 employees Four Areas of Focus  Reducing the spread of infection  Advancing global health  Enhancing therapy  Improving disease management Africa Presence  120 Employees  Offices in Johannesburg, Nairobi and Accra  Distribution, service and support network

Progress in TB Diagnostics for the Developing World 2010 Future ?

Product Development Technology Development Implementation Service and Support Biomarkers Specimen collection Rapid turnaround Sensitivity and specificity Validation studies Cost efficient Clinical trials New Diagnostics: A Common Perception Dx ACCESS

BD Product Development Process ImplementationQualificationDevelopmentDefinitionConcept Customer Voices Business Voices Customer Requirements Operational Requirements Product Requirements Process Requirements Product Specifications Process Specification Verification Units Validation Units Process Validation Manufacturing Engineering Prototypes Pilot Manufacturing Support Pricing Regulatory Laboratory Strengthening Advocacy and Policy Service/Repairs Training Set Up

TB Diagnostics R&D: Design Challenges Need for improved laboratory capacity Roads, electricity, cold chain Regulatory hurdles Lack of trained personnel

Patients who need to be treated are not reached Specimens from non-responding patients need to be referred Stakeholders have had difficulty routing specimens to the NTRL Verification of microscopy results and the response to blinded re- checking of smears is incomplete Used GPS technology to map patient sample collection sites Created reference network and ability to gather data Trained on proper TB specimen collection and transport More than 1000 patient samples referred and more than 900 sites mapped BD Example: Uganda Specimen Referral Program

Private Sector Core Competencies –Public/private and private/private collaboration Technology development Advocacy –Project management Working with local MoH –Training and education Leverage employee skill-set Strengthen healthcare capacity Implementation and Support Dx ACCESS

Conclusions Effective R&D considers implementation/service up front –Anything can work in a laboratory or work in the field once – replicability and sustainability is essential Incentives should not only be for technology/product development –Look for incentives on implementation and service as well Leverage core competencies of the private sector –Multi-faceted problems require collaborative approach

Thank You